Probare i Lund AB Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2011
NCT01447017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

ProbarE, Lund

Active Ingredients

Drugs in Phase 2 Trials (2)

dpk-060 (1 trial)

iodocarb (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 2)

Fatigue Syndrome, Chronic (Phase 2)

Otitis (Phase 2)

Otitis Externa (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2